HDL-cholestérol et approche thérapeutique
Publication
, Journal Article
Bruckert, E; Ferrières, J; Farnier, M
Published in: Archives of Cardiovascular Diseases Supplements
December 2011
Duke Scholars
Published In
Archives of Cardiovascular Diseases Supplements
DOI
ISSN
1878-6480
Publication Date
December 2011
Volume
3
Issue
4
Start / End Page
273 / 279
Publisher
Elsevier BV
Related Subject Headings
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Bruckert, E., Ferrières, J., & Farnier, M. (2011). HDL-cholestérol et approche thérapeutique. Archives of Cardiovascular Diseases Supplements, 3(4), 273–279. https://doi.org/10.1016/s1878-6480(11)70786-8
Bruckert, E., J. Ferrières, and M. Farnier. “HDL-cholestérol et approche thérapeutique.” Archives of Cardiovascular Diseases Supplements 3, no. 4 (December 2011): 273–79. https://doi.org/10.1016/s1878-6480(11)70786-8.
Bruckert E, Ferrières J, Farnier M. HDL-cholestérol et approche thérapeutique. Archives of Cardiovascular Diseases Supplements. 2011 Dec;3(4):273–9.
Bruckert, E., et al. “HDL-cholestérol et approche thérapeutique.” Archives of Cardiovascular Diseases Supplements, vol. 3, no. 4, Elsevier BV, Dec. 2011, pp. 273–79. Crossref, doi:10.1016/s1878-6480(11)70786-8.
Bruckert E, Ferrières J, Farnier M. HDL-cholestérol et approche thérapeutique. Archives of Cardiovascular Diseases Supplements. Elsevier BV; 2011 Dec;3(4):273–279.
Published In
Archives of Cardiovascular Diseases Supplements
DOI
ISSN
1878-6480
Publication Date
December 2011
Volume
3
Issue
4
Start / End Page
273 / 279
Publisher
Elsevier BV
Related Subject Headings
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology